Bumetanide
NDC 16571-678, bumetanide, tablet, from Rising Pharma Holdings, Inc.
- Product NDC
- 16571-678
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212019
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-678 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUMETANIDE1 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-678-01 | 16571067801 | 100 TABLET in 1 BOTTLE (16571-678-01) |
| 16571-678-10 | 16571067810 | 1000 TABLET in 1 BOTTLE (16571-678-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/627c9732-eed1-4435-8d79-2e19ab974fd9NADAC price for package 16571067801
GET /v1/drugs/nadac/16571067801
Use it
Look up 16571-678 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-678 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-678. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.